EUVIMEDEUVIMED entdecken
Editorial

Theranostics: Timing is Everything

J Harvey Turner iD

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2024.0088 ↗

Kurz gefasst

Editorial in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von J Harvey Turner. Beteiligte Einrichtung: Department of Nuclear Medicine, Fiona Stanley Fremantle Hospitals Group, The University of Western Australia, Murdoch, Australia. Hauptthemen laut MEDLINE: Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineHumansNeoplasmsNuclear MedicineRadiopharmaceuticalsTheranostic NanomedicineTime Factors

Stichwörter der Autor:innen

dosimetryphronesisradioligand FAPI pancreas cancer therapysequencingtheranostic nuclear medicine

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fiona Stanley Fremantle Hospitals Group, The University of Western Australia, Murdoch, Australia.

ORCID-Profile: J Harvey Turner

Zitieren

APA

Turner, J. H. (2024). Theranostics: Timing is Everything. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0088

Vancouver

Turner JH. Theranostics: Timing is Everything. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2024.0088

BibTeX
@article{Turner2024,
  author = {Turner, J Harvey},
  title = {Theranostics: Timing is Everything},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2024.0088}
}
Kostenlos starten →